Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year
Obesity · 2026
DOI: 10.1002/oby.70291 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Obesity, 2026. Verfasst von Abdelrahman M Elshakankiry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Overweight, Weight Loss. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NCRR NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
This study aimed to quantify changes in predicted 10‐year risk for major adverse cardiovascular events (MACE) and type 2 diabetes (T2D) across weight loss, post–weight loss (Post‐WL), and 1‐year follow‐up and to determine whether trajectories varied by exercise modality.
Methods
Sedentary women with overweight (21–49 years) were randomized to Diet+Aerobic, Diet+Resistance, or Diet‐only and completed an 800 kcal/day diet until BMI < 25 kg m −2 . Predicted 10‐year MACE and T2D risks were calculated using cardiometabolic disease staging equations. Longitudinal changes and adherence effects were analyzed using fractional logit models fit with generalized estimating equations.
Results
Among 221 women (115 African American), mean BMI decreased from 28.3 to 23.9 kg m −2 , with regain to 25.8 at 1 year. MACE risk decreased from Baseline to Post‐WL and rebounded from Post‐WL to 1 year in all groups (all p < 0.001). Diet‐only achieved greater MACE reduction than Diet+Resistance ( p = 0.022). T2D risk decreased in all groups (all p < 0.001) but rebounded in Diet+Aerobic and Diet‐only. The Diet+Resistance group maintained a significant net reduction at 1 year ( p = 0.003). Follow‐up exercise adherence was associated with lower T2D risk rebound ( p = 0.024).
Conclusions
Weight loss reduced MACE and T2D risks, but both rebounded with weight regain. Resistance exercise may be beneficial in weight loss interventions to prevent progression to T2D. Trial Registration ClinicalTrials.gov identifier: NCT00067873
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Human Studies, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Medicine, Division of Internal General Medicine and Population Science, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Abdelrahman M Elshakankiry, Gary R Hunter, Cátia Martins, Gordon Fisher, W Timothy Garvey, Carrie R Howell
Förderung
- NIH HHS
- NIDDK NIH HHS
- NCRR NIH HHS
- National Institutes of Health
Zitieren
APA
Elshakankiry, A. M., Hunter, G. R., Martins, C., Fisher, G., Garvey, W. T., & Howell, C. R. (2026). Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year. Obesity. https://doi.org/10.1002/oby.70291
Vancouver
Elshakankiry AM, Hunter GR, Martins C, Fisher G, Garvey WT, Howell CR. Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year. Obesity. 2026. doi:10.1002/oby.70291
BibTeX
@article{Elshakankiry2026,
author = {Elshakankiry, Abdelrahman M and Hunter, Gary R and Martins, Cátia and Fisher, Gordon and Garvey, W Timothy and Howell, Carrie R},
title = {Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70291}
}
EUVIMED